These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7485082)

  • 1. CD2+, CD3-, CD56/NCAM+ malignant lymphoma with TCR beta gene rearrangement: a case report.
    Savilo E; Meyer RM; Soamboonsrup P; Sunisloe L; Frank GL; Simon GT; Neame PB
    Am J Hematol; 1995 Nov; 50(3):209-14. PubMed ID: 7485082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
    Kato N; Yasukawa K; Onozuka T; Kikuta H
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract.
    Nakamura S; Suchi T; Koshikawa T; Kitoh K; Koike K; Komatsu H; Iida S; Kagami Y; Ogura M; Katoh E
    Am J Surg Pathol; 1995 Mar; 19(3):284-96. PubMed ID: 7532919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
    Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
    Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus.
    Kagami Y; Nakamura S; Suzuki R; Iida S; Yatabe Y; Okada Y; Kobayashi T; Tsurumi T; Seto M; Ogura M; Taguchi O; Morishima Y
    Br J Haematol; 1998 Dec; 103(3):669-77. PubMed ID: 9858215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.
    Emile JF; Boulland ML; Haioun C; Kanavaros P; Petrella T; Delfau-Larue MH; Bensussan A; Farcet JP; Gaulard P
    Blood; 1996 Feb; 87(4):1466-73. PubMed ID: 8608237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
    Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R
    Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR-CD56+CD2+ nasal lymphomas with membrane-localized CD3 positivity: are the CD3+ cells neoplastic or reactive?
    Tao Q; Chiang AK; Srivastava G; Ho FC
    Blood; 1995 May; 85(10):2993-6. PubMed ID: 7537987
    [No Abstract]   [Full Text] [Related]  

  • 10. A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature.
    Kameoka J; Ichinohasama R; Tanaka M; Miura I; Tomiya Y; Takahashi S; Yamada M; Ishikawa I; Kadowaki I; Sasaki O; Kimura J; Meguro K; Ooya K; Ito S
    Am J Clin Pathol; 1998 Oct; 110(4):478-88. PubMed ID: 9763034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
    Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
    J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma.
    Di Noto R; Pane F; Camera A; Luciano L; Barone M; Lo Pardo C; Boccuni P; Intrieri M; Izzo B; Villa MR; Macrí M; Rotoli B; Sacchetti L; Salvatore F; Del Vecchio L
    Leukemia; 2001 Oct; 15(10):1641-9. PubMed ID: 11587224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression.
    Richards SJ; Scott CS
    Leuk Lymphoma; 1990; 2(1-2):111-26. PubMed ID: 27456578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteropathy-type T-cell lymphoma expressing NK-cell intraepithelial lymphocyte (NK-IEL) phenotype.
    Inagaki N; Asaoka D; Mori KL; Sohda N; Miura I; Miwa H; Sato N; Oshimi K
    Leuk Lymphoma; 2004 Jul; 45(7):1471-4. PubMed ID: 15359651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant lymphoma originating from the earliest T-lineage precursor cell.
    Hashimoto Y; Yasukawa M; Takada K; Hato T; Fujita S
    Am J Hematol; 1993 Aug; 43(4):319-21. PubMed ID: 7690521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of CD16 and CD56 expression in persistent expansions of CD3+NKa+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. The Yorkshire Leukaemia Group.
    Sivakumaran M; Richards SJ; Hunt KM; Steed AJ; Bynoe AG; Morgan MM; Pyrah R; Roberts BE; Scott CS
    Br J Haematol; 1991 Jul; 78(3):368-77. PubMed ID: 1714758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia.
    Gentile TC; Uner AH; Hutchison RE; Wright J; Ben-Ezra J; Russell EC; Loughran TP
    Blood; 1994 Oct; 84(7):2315-21. PubMed ID: 7522625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin. Report of two cases and review of the literature.
    Ansai S; Maeda K; Yamakawa M; Matsuda M; Saitoh S; Suwa S; Saitoh H; Ohtsuka M; Iwatsuki K
    J Cutan Pathol; 1997 Sep; 24(8):468-76. PubMed ID: 9331892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin.
    Uchiyama N; Ito K; Kawai K; Sakamoto F; Takaki M; Ito M
    Am J Dermatopathol; 1998 Oct; 20(5):513-7. PubMed ID: 9790118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.